Intellego Technologies Updates On HAI Solutions' FDA Application
T-Reuters
2023-03-27
Intellego Technologies AB :Updates On Hai Solutions.End Product That Hai Sells Is Medical Device, Is Subject To Approval From Fda.Hai Will Shortly Submit Its Fda Application And Has In Dialogue With Fda Been Informed That Fda Approval For Application Should Come At End Of 2023.As Product Has Low Risk Classification, There Are No Significant Obstacles To Fda Authorisation.